Theophylline sodium glycinate/Guaifenesin

甘氨酸茶碱钠/愈创甘油醚

Report date: 2025/07/18 17:33:10

Base Information

Drug NameTheophylline sodium glycinate/Guaifenesin
Drug Alias Name复方甘氨酸茶碱钠
ClassificationSmall molecules
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date2003/04/23
Country/TerritoryMainland China
CombinationsYes Theophylline sodium glycinateGuaifenesin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJilin Province Huinan Changlong Bio-Pharmacy Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJilin Province Huinan Changlong Bio-Pharmacy Company Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A